Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized, Double-blind, Sham Controlled Multi-center Clinical Trial, Migraine Headache Treatment With Nerivio Migra Neurostimulation Device

NCT03076515 is registered in ClinicalTrials.gov with Theranica as lead sponsor.

NCT NCT03076515
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03076515 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized, Double-blind, Sham Controlled Multi-center Clinical Trial, Migraine Headache Treatment With Nerivio Migra Neurostimulation Device
Lead sponsor
Theranica
Phase
Not applicable
Overall status
Terminated
Start date
April 2, 2017
Completion date
April 1, 2018
Enrollment
120 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute migraine